c-Fos-driven transcriptional activation of transforming growth factor β-1: inhibition of high glucose-induced promoter activity by thiazolidinediones
- 2 May 2003
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 304 (2), 301-307
- https://doi.org/10.1016/s0006-291x(03)00599-0
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Angiotensin II induces human TGF-β1 promoter activation: similarity to hyperglycaemiaDiabetologia, 2002
- Repression of Glucagon Gene Transcription by Peroxisome Proliferator-activated Receptor γ through Inhibition of Pax6 Transcriptional ActivityPublished by Elsevier ,2002
- Expression and Function of Peroxisome Proliferator–Activated Receptor-γ in Mesangial CellsHypertension, 2001
- Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansionKidney International, 2000
- DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrationsKidney International, 1998
- Troglitazone Has a Scavenging Effect on Reactive Oxygen SpeciesBiochemical and Biophysical Research Communications, 1997
- Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma.Journal of Clinical Investigation, 1996
- Inhibition of oxidation of low density lipoprotein by troglitazoneAtherosclerosis, 1996
- High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell culturesKidney International, 1994
- Glomerular epithelial, mesangial, and endothelial cell lines from transgenic miceKidney International, 1988